EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs

Yoonhee Kim, Wonhee Lee, Byunggak Kim, Bonghwan Jang, Kyung-Rok Yu, Hong Sook Kim, Minok Ryu iD, Yein Oh iD, Kyoungwon Seo iD, Chul Park, Ulsoo Choi iD, Dongha Bhang iD and 1 more

Journal of Veterinary Internal Medicine · 2025

DOI: 10.1111/jvim.17266 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2025. Written by Yoonhee Kim and 12 co-authors. Institution: Department of Veterinary Clinical Pathology, College of Veterinary Medicine, Jeonbuk National University, Iksan-si, Jeollabuk-do, Republic of Korea. Major MEDLINE topics: Thymidine Kinase, Dog Diseases, Autoantibodies, Neoplasms. Cited 3 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Biattic Inc..

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Although the importance of early diagnosis of malignant tumors is a major concern, an easily accessible in-house method has not been established.

Objectives

To investigate the most optimal model by combining thymidine kinase 1 (TK1) autoantibody, extracellular protein kinase A (ECPKA) autoantibody, TK1 antigen, C-reactive protein (CRP), age, breed, and sex. Animals Serum samples from 1702 dogs were collected from local animal hospitals and referral animal medical centers in Korea.

Methods

TK1 autoantibody, ECPKA autoantibody, and CRP were measured using LFIA methods in serum samples of dog to design a new neoplastic index (NI) for early detection of malignant tumors in dogs.

Results

AUC of TK1 autoantibody model with TK1 antigen, CRP, age, and breed in multiple logistic regression analysis was 0.966 (TK1 autoantibody, P = .0005; TK1 antigen, P = .0003), and when the cutoff value was 0.417, the specificity was 87.1%, and sensitivity was 96.4%. Regression coefficients were 24.4, 20.5, 24.8, 10.6, respectively in TK1 autoantibody, TK1 antigen, CRP, and age, and the effect by breed (regression coefficient 2.1, 3.0) was the lowest. The same multiple logistic regression analysis on dogs with lymphoma, and AUC of TK1 autoantibody model was 0.981 (all P < .0001, TK1 antigen P = .09), when the cutoff value was 0.352, the specificity was 92.9%, and sensitivity was 93.7%. Conclusions and Clinical Importance The NI including TK1 autoantibody could be useful in the screening test for both lymphoma and other tumors.

Subjects

MeSH terms (MEDLINE)

Thymidine KinaseDog DiseasesAutoantibodiesNeoplasmsC-Reactive ProteinAnimalsDogsFemaleMaleEarly Detection of CancerSensitivity and SpecificityBiomarkers, Tumor

Author keywords

C‐reactive proteinautoantibodiesextracellular protein kinase Amalignant tumorneoplastic indexthymidine kinase 1

Substances

Thymidine Kinasethymidine kinase 1AutoantibodiesC-Reactive ProteinBiomarkers, Tumor

Authors and institutions

  • Department of Veterinary Clinical Pathology, College of Veterinary Medicine, Jeonbuk National University, Iksan-si, Jeollabuk-do, Republic of Korea.
  • Biattic Inc., #306, 16, Heungan-daero 427beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Republic of Korea.
  • Good-Morning-Pet Animal Hospital, Jeongjail-ro 55, Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul, South Korea.
  • Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, South Korea.
  • Department of Biological Sciences, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, South Korea.
  • Seoul National University College of Veterinary Medicine, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea.

ORCID profiles: Minok Ryu, Yein Oh, Kyoungwon Seo, Ulsoo Choi, Dongha Bhang, Hwayoung Youn

Funding

  • Biattic Inc.

Cite

APA

Kim, Y., Lee, W., Kim, B., Jang, B., Yu, K. R., Kim, H. S., Ryu, M., Oh, Y., Seo, K., Park, C., Choi, U., Bhang, D., & Youn, H. (2025). Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17266

Vancouver

Kim Y, Lee W, Kim B, Jang B, Yu KR, Kim HS, et al. Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.17266

BibTeX
@article{Kim2025,
  author = {Kim, Yoonhee and Lee, Wonhee and Kim, Byunggak and Jang, Bonghwan and Yu, Kyung-Rok and Kim, Hong Sook and Ryu, Minok and Oh, Yein and Seo, Kyoungwon and Park, Chul and Choi, Ulsoo and Bhang, Dongha and Youn, Hwayoung},
  title = {Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  doi = {10.1111/jvim.17266}
}
Start for free →